Conservative B cell epitope peptide based on gE protein and application of B cell epitope peptide in diagnosis of porcine pseudorabies virus antibody

CN119775368AActive Publication Date: 2025-04-08YANGZHOU UNIV +1
-1 Cites -1 Cited by

Patent Information

Application Number
CN202411788236.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-12-06
Publication Date
2025-04-08
Estimated Expiration
2044-12-06

Smart Images

  • Figure CN119775368A_ABST
    Figure CN119775368A_ABST
Patent Text Reader

Abstract

The invention discloses a conservative B cell epitope peptide on surface envelope glycoprotein of porcine pseudorabies virus (PRV) and application of the conservative B cell epitope peptide in PRV antibody diagnosis. The sequence of the PRV gE conservative linear B cell epitope is GPGGGD, and the PRV gE conservative linear B cell epitope is named as GD-GG. The B cell epitope can be subjected to functional exhibition expression on the surface of an inert carrier S9H thallus, only a PRV infection antibody is specifically detected by a GD-GG-antibody direct mediated agglutination test detection method established on the basis of GD-GG subjected to exhibition expression on the surface of the S9H thallus, and the B cell epitope has no cross reaction with other porcine infectious disease antibodies. And if two amino acids GG in the GD-GG sequence are mutated into RR, namely GPGGGD is mutated into GPRRGD, the specific binding reaction with the PRV infected antibody is avoided. The diagnosis method has the advantages of high specificity, convenience in operation, intuitive result judgment and the like, and is expected to become a technical means for accurate and visual diagnosis of PRV infection.
Need to check novelty before this filing date? Find Prior Art